OAKS, Pa., Sept. 20 /PRNewswire/ -- DSG, the industry’s largest privately- held EDC (electronic data capture) solutions provider, has been awarded a multi-national Phase II clinical trial using their proprietary technology, eCaseLink EDC 6.0 with CaseView. The study is one of several oncology trials that will use the CaseView feature to upload and review MRI images to determine the suitability of patient’s participation within the study. Since its deployment earlier this year, eCaseLink EDC 6.0 with CaseView has been chosen for over 35 new clinical trials.
One of the world’s largest producers of branded and generic drugs chose DSG’s eCaseLink EDC 6.0 specifically for the CaseView feature. The corporation has one of the largest oncology, respiratory and central nervous system pipelines in the world and will use eCaseLink EDC 6.0 for several additional upcoming oncology trials. CaseView allows anyone involved in a clinical trial the ability to upload, download, review and comment on medical records and images. eCaseLink EDC 6.0 will be used to review MRI images of brain tumors to determine a patient’s eligibility in a study - decreasing patient recruitment needs, as well as determining the safest test population for the study. eCaseLink EDC 6.0 is the only electronic data capture solution on which this functionality is available.
In addition to oncology trials, eCaseLink EDC 6.0 with CaseView will be used in a number of other therapeutic areas this year including ophthalmology, cardiovascular, central nervous system, and women’s health.
“We are very pleased that one of the world’s foremost pharmaceutical corporations has chosen eCaseLink for their oncology studies,” said Tony Varano, President and CEO of DSG, Inc. “eCaseLink technology is unique in the EDC industry, as it allows the most robust features of any clinical data analysis tool. By using eCaseLink to review and comment on MRI images, our client will have the fastest study set-up time, eliminate patient recruitment issues, and increase patient safety, at cost-effective rates. Our mission is to provide our clients with the most innovative solutions on the market. With eCaseLink EDC 6.0, we have the experience, the technology, and we deliver.”
About DSG, Inc.
Since 1992, DSG, Inc. has been supporting clinical trial data collection with innovative technology solutions including EDC, ePRO and digital on-demand CRF publishing software to over 300 companies in the life science industry. DSG’s products allow friendly, accurate and efficient data capture at any investigator site regardless of the site’s technological infrastructure. ECaseLink(TM), DSG’s pioneering EDC technology, allows site users immediate server edits, without the traditional need to first save or submit, is fully integrated with eDiaryLink(TM) ePRO, and offers the highest site acceptance, fastest submission speed, and nominal set-up time. DSG has successfully supported over 250 clinical trials, at over 14,000 sites, with over 200,000 patients worldwide. For more information, please visit http://www.dsg-us.com.
DSG, Inc.
CONTACT: Tammi E. Lake, DSG, Inc., +1-610-676-0386, tlake@dsg-us.com
Web site: http://www.dsg-us.com/
